• Publications
  • Influence
Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital
BACKGROUND Analysis of malignant lymphoma in a single institution at different periods of time can determine the changing status of the disease in the region. METHODS To compare with the largeExpand
Clinical Manifestation of &bgr;-Thalassemia/Hemoglobin E Disease
Purpose To review the clinical manifestation and changes in hematologic parameters of patients with &bgr;-thalassemia/hemoglobin (Hb) E. Materials and Methods Retrospective analysis of the clinicalExpand
Screening for the carriers of thalassemias and abnormal hemoglobins at the community level.
Thalassemia and abnormal hemoglobins are common genetic disorders in Southeast Asia. Thalassemia is not only an important public health problem but also a socio-economic problem of many countries inExpand
Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group.
The annual incidence of aplastic anemia in metropolitan Bangkok, Thailand, and its five suburban provinces was prospectively determined. All patients first diagnosed during the period from JanuaryExpand
Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group.
Agranulocytosis, a syndrome characterized by a marked reduction in circulating granulocytes, is strongly associated with medical drug use in Europe and the United States. Unregulated use of commonExpand
Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia.
Several different kinds of thalassemia and hemoglobinopathy are prevalent in Southeast Asia.1,2 The frequency of the α-thalassemias reaches 30 to 40 percent in northern Thailand, whereas theExpand
Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC.
The conventional approach to qualitative and quantitative analyses of hemoglobin (Hb) molecules for the diagnoses of hemoglobinopathies requires a combination of tests. We used an automated HPLCExpand
Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
Hydroxyurea (HU) is one of several agents that have been shown to enhance hemoglobin (Hb) F levels in patients with sickle cell disease and may be useful as a therapy for beta-globinopathies.Expand
Fatal arteritis due to Pythium insidiosum infection in patients with thalassaemia.
Six thalassaemic patients had a distinct clinical syndrome characterized by progressive ischemia of the lower extremities, with ascending arteritis and thrombosis of the main arteries of the lowerExpand